TERT and cancer: For source of control, however, only one homozygote comparison (CT vs. TT: OR = 1.124, 95% CI = 1.026–1.230; P = 0.012) in the population-based control source showed a significant association between the TERT rs2853669 polymorphism and cancer risk.